Atypical Presentation of Multidrug-Resistant Acinetobacter baumannii Pneumonia in a Post-Surgical ICU Patient: A Case Report
Abstract
Acinetobacter baumannii is a Gram-negative opportunistic pathogen increasingly encountered in hospital environments, particularly in intensive care units (ICUs), where it presents a major clinical challenge due to its multidrug-resistant (MDR) profile. Its resistance to multiple antibiotic classes makes it a serious therapeutic challenge, particularly in post-surgical patients where symptoms may be atypical. We report a case of a previously healthy 64-year-old male patient with a history of hypertension and coronary artery disease, admitted to the ICU following elective abdominal aortic aneurysm repair. On postoperative day five, he developed mild respiratory symptoms, low-grade fever, and oxygen desaturation, but with no abnormal lung auscultation findings. Elevated inflammatory markers and radiologic evidence of faint bilateral perihilar infiltrates and subtle ground-glass opacities prompted further investigation. Cultures revealed MDR A. baumannii resistant to carbapenems, aminoglycosides, and fluoroquinolones, but susceptible to colistin and tigecycline. The patient received combination intravenous therapy with colistin and tigecycline, resulting in rapid clinical improvement, normalization of inflammatory markers, and complete radiologic resolution by day 14. This case underscores the importance of maintaining a high index of suspicion for MDR pneumonia in post-surgical ICU patients with non-specific symptoms and highlights the role of early diagnosis and targeted…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.